CV
Senior clinical research professional with expertise in pharmaceutical development, regulatory compliance, and bioequivalence studies.
Basics
| Name | Ahmet Ozan ÖZGEN |
| Label | Pharm. (MSc) | Senior Clinical Research Specialist |
| ozan_ozgen@outlook.com | |
| Phone | +90 505 759 2056 |
| Url | https://pharmozgen.me |
| Summary | Clinical research and business development professional with expertise in bioavailability and bioequivalence studies, clinical trials, regulatory compliance, contracts, and stakeholder management. Applies data science and programming to healthcare and pharmaceutical research problems. |
Work Experience
-
2023.04 - Present Istanbul, Türkiye
Senior Clinical Research Specialist
Nobel İlaç
Supports clinical research and bioequivalence activities, regulatory documentation, stakeholder communication, workflow automation, and compliance improvement in a pharmaceutical environment.
-
2020.06 - 2023.04 Istanbul, Türkiye
Business Development Executive
Biocalis
Supported healthcare business development, account management, market research, and portfolio activities across international markets.
-
2019.08 - 2020.06 Istanbul, Türkiye
Retail Pharmacist
Avaroğlu Pharmacy
Provided patient-focused medication support and contributed to daily pharmacy operations.
-
Antalya and Istanbul, Türkiye
Student Intern
University Hospital, Retail Pharmacies, and Pharmaceutical Company
Completed hospital, retail pharmacy, and pharmaceutical industry internships.
Networks and Memberships
-
2022.07 - 2023.01 Istanbul and Athens
ICT Talent Program Participant and Team Lead
Huawei Seeds for the Future
Led a team of 10 that developed an AI-driven concept to prevent violence against healthcare workers. The team won the Türkiye stage of the competition and participated in the European Talent Summit in Athens.
- Team leadership
- Artificial intelligence
- Healthcare innovation
-
2019.10 - 2023.08 Istanbul, Türkiye
Youth Assembly and Assistant Pharmacists Commission Member
Istanbul Chamber of Pharmacists
Contributed to projects connecting the UN Sustainable Development Goals with pharmacy practice and volunteered for one week at a field pharmacy in Antakya after the 6 February 2023 earthquakes.
- Sustainable development
- Pharmacy disaster response
-
2017.10 - 2019.10 Istanbul, Türkiye
Youth Delegate
Istanbul Chamber of Pharmacists, Youth Assembly
Represented Istanbul Medipol University for two years and helped organize the first and second Pharmacist Youth Meetings in 2018 and 2019.
- Representation
- Event coordination
Education
Publications
-
2026 Pharmacokinetic Profile and the Bioequivalence Study of Macitentan FCT in Healthy Volunteers
Nobel Medicus (Research Article, Preprint)
Preprint.
-
2024 In Silico Investigation of Anticancer Properties of Antimicrobial Peptides
Council of Higher Education (MSc Dissertation)
Developed a random-forest model using amino-acid and dipeptide features to predict anticancer activity in antimicrobial peptides.
-
2023 Pharmacokinetic Profile and a Bioequivalence Study of Apixaban in Healthy Volunteers
Nobel Medicus
Reported a randomized crossover study demonstrating bioequivalence between test and reference apixaban tablets.
-
2023 Enzymatic Targets for Drug Discovery Against Alzheimer's Disease
Bentham Science (Book Chapter)
Reviewed enzyme-related therapeutic targets associated with Alzheimer's disease and their clinical significance.
-
2022 Models of Spike, Envelope and Membrane Proteins of SARS-CoV-2 Variants for Possible Therapeutics
Journal of Medical Topics and Updates
Compared mutations in SARS-CoV-2 structural proteins across variants of concern to identify potential therapeutic targets.
-
2020 Antibiotic Susceptibility of Klebsiella pneumoniae Strains Isolated from Clinical Samples
Journal of the Turkish Chemical Society Section A: Chemistry
Analyzed antimicrobial susceptibility patterns in 502 clinical Klebsiella pneumoniae isolates.
Presentations
-
2026.11 In Silico Investigation of Anticancer Properties of Antimicrobial Peptides
IPC Abstract Book, O55 - Oral Presentation
-
2026.11 Correlation Between Safety Issues and Success in Clinical Trials of ATMPs
IPC Abstract Book, O13 - Oral Presentation
-
2025.11 In Silico Investigation of Anticancer Properties of Antimicrobial Peptides
IPC Abstract Book, 0240 - Oral Presentation
-
2024.11 Document Classification with Optical Character Recognition and Support Vector Machines in Clinical Research
6th CRC Abstract Book, 28-30 - Poster Presentation
-
2023.12 Pharmacovigilance Training for 600+ Employees
Nobel İlaç End-of-Year Meeting, Antalya - Trainer
-
2023.11 Pharmacoeconomic Evaluation of Ulcerative Colitis and Crohn's Disease Treatments in Türkiye in Terms of Biosimilars
IPC Abstract Book, 276-277 - Oral Presentation
-
2023.09 Pharmacoeconomic Evaluation of Nusinersen for Spinal Muscular Atrophy in Türkiye
BIO Türkiye Abstract Book, 56-57 - Oral Presentation
-
2022.09 Medical Implants - SEBBIN
ISAPS 2022, Istanbul - Exhibitor
-
2022.03 Artificial Intelligence in Pharmacy
8th National Congress of Hospital and Institutional Pharmacists - Guest Speaker
-
2022.02 In Silico Stability of Matrixyl Peptide Solution in Thermal Stress
IPTS 2022 Abstract Book, 175-177 - Oral Presentation
-
2021.11 Pharmacoeconomic Evaluation of Biosimilars in Developing Countries
IPC Abstract Book, 240-243 - Oral Presentation
-
2019.09 Antibiotic Susceptibility of Klebsiella pneumoniae Strains Isolated from Clinical Samples
NCC Abstract Book, 372 - Poster Presentation
Certificates
| Qualified Person Responsible for Pharmacovigilance (QPPV) | ||
| Turkish Medicines and Medical Devices Agency (TİTCK) | 2024 |
| Good Clinical Practice Training | ||
| Turkish Clinical Research Association | 2023 |
| Driver's License (B) | ||
| Statistics School | ||
| Akdeniz University - 8-week program |
| Pharmaceutical Industry Education Program | ||
| MUEF & TISD - 8-week program |
| McKinsey Forward Program | ||
| McKinsey Academy |
| Internal Auditor (ISO 9001:2015) | ||
| DataLonga AI School | ||
| 13-week education program |
Skills
| Regulatory & Compliance | |
| ICH-GCP | |
| ICH, EMA, and FDA guidelines | |
| Data integrity | |
| GDPR |
| Technical | |
| Clinical and non-clinical CTD preparation and assessment | |
| Python and R for machine learning | |
| SQL |
| Professional | |
| Cross-functional collaboration | |
| Stakeholder management | |
| Effective delegation | |
| Contract negotiation |
Languages
| Turkish | |
| Native language |
| English | |
| Full professional proficiency (IELTS: 7.5 | eYDS: 92.5) |
Interests
| Advanced Therapeutics | |
| Clinical development | |
| Technology transfer | |
| International regulatory guidelines |
| Bioinformatics | |
| Machine learning | |
| Programming | |
| Preclinical development | |
| Drug discovery |
Projects
- 2024 - Present
Machine Learning for Anticancer Peptides
Developed a patent-pending machine-learning method to determine anticancer activity in peptides.
- Bioinformatics
- Random forest
- Drug discovery
- 2023 - Present
Clinical Research Automation and Digitalization
Integrated IMP procurement and regulatory requests, built RPA tracking for study timelines and EC/MoH applications, and developed a RAG system for regulatory guidelines.
- RPA
- Clinical trials
- Regulatory compliance
- Retrieval-augmented generation